Exagen Inc.

Exagen Inc.verified

XGN

Price:

$2.47

Market Cap:

$42.94M

Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by...[Read more]

Industry

Medical - Diagnostics & Research

IPO Date

2019-09-19

Stock Exchange

NASDAQ

Ticker

XGN

The Enterprise Value as of November 2024 (TTM) for Exagen Inc. (XGN) is 42.34M

According to Exagen Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 42.34M. This represents a change of 43.54% compared to the average of 29.50M of the last 4 quarters.

Exagen Inc. (XGN) Historical Enterprise Value (quarterly & annually)

How has XGN Enterprise Value performed in the past?

The mean historical Enterprise Value of Exagen Inc. over the last ten years is 62.15M. The current 42.34M Enterprise Value has changed 6.71% with respect to the historical average. Over the past ten years (40 quarters), XGN's Enterprise Value was at its highest in in the December 2019 quarter at 272.81M. The Enterprise Value was at its lowest in in the September 2019 quarter at -28532702.39.

Quarterly (TTM)
Annual

Average

62.15M

Median

18.68M

Minimum

2.17M

Maximum

272.82M

Exagen Inc. (XGN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Exagen Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.05%

Maximum Annual Enterprise Value = 272.82M

Minimum Annual Increase = -88.48%

Minimum Annual Enterprise Value = 2.17M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202322.41M70.97%
202213.11M-88.48%
2021113.79M-16.46%
2020136.22M-50.07%
2019272.82M2.05%
201812.70M44.94%
20178.77M-64.31%
201524.56M64.18%
201414.96M589.59%
20132.17M327.16%

Exagen Inc. (XGN) Average Enterprise Value

How has XGN Enterprise Value performed in the past?

The current Enterprise Value of Exagen Inc. (XGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

49.77M

5-year avg

111.67M

10-year avg

62.15M

Exagen Inc. (XGN) Enterprise Value vs. Peers

How is XGN’s Enterprise Value compared to its peers?

Exagen Inc.’s Enterprise Value is less than FONAR Corporation (77.41M), greater than Burning Rock Biotech Limited (-220828385.09), less than Sera Prognostics, Inc. (254.28M), less than Olink Holding AB (publ) (3.16B), less than LumiraDx Limited (377.41M), greater than Genetron Holdings Limited (-48977790.00), less than Castle Biosciences, Inc. (872.68M), less than Sotera Health Company (6.57B), greater than Psychemedics Corporation (14.11M), greater than DarioHealth Corp. (35.65M), less than Biodesix, Inc. (232.35M),

Build a custom stock screener for Exagen Inc. (XGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Exagen Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Exagen Inc. (XGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Exagen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Exagen Inc.'s Enterprise Value?

What is the highest Enterprise Value for Exagen Inc. (XGN)?

What is the 3-year average Enterprise Value for Exagen Inc. (XGN)?

What is the 5-year average Enterprise Value for Exagen Inc. (XGN)?

How does the current Enterprise Value for Exagen Inc. (XGN) compare to its historical average?